Skip to main content
OpenTrials
Completed

NCT Number: NCT02477930

Endosponge Vacuum Therapy (E-VAC) Registry of Intestinal Anastomotic Leaks and Perforations

The purpose of this registry is to collect data on the clinical use of endoluminal vacuum (E-Vac) therapy to treat both upper and lower intestinal leaks and perforations.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Baylor University Medical Center

Dallas, Texas, 75246, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All patients undergoing E-Vac Therapy
  • Age > 17 years

Exclusion criteria

  • 17 years of age or younger
  • Undergone an E-Vac placement > 14 days before consenting

Treatment and study plan

No interventions are done

Other

No intervention is done. This is a registry study.

Primary outcomes

  1. In-Hospital survival-rate

    Time frame: 6 months

Sponsors and collaborators

Lead sponsor

Baylor Research Institute

Other

Registry information

Official study title

Prospective Registry The Treatment Of Upper And Lower Intestinal Anastomotic Leaks And Perforations

Important dates

Study start
2014
Primary completion
2023
Study completion
2023
First posted
Jun 23, 2015
Registry last updated
May 25, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.